Results 71 to 80 of about 2,534,031 (236)
Asia-Pacific Journal of Clinical Oncology, EarlyView.RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan +17 more
wiley +1 more source
Ocular Manifestations of Stevens-Johnson Syndrome [PDF]
, 2021 The purpose of this case report was to have a further study of the proper management of ocular manifestations caused by Stevens-Johnson Syndrome, which aims to minimize the chances of complications. This case report will discuss the ocular manifestations
Doemillah, Ratna +1 more
core +2 more sources
Reactive Infectious Mucocutaneous Eruption (RIME): An Australian Case Series
Australasian Journal of Dermatology, EarlyView.ABSTRACT Whilst Reactive Infectious Mucocutaneous Eruption (RIME) displays a low mortality rate, the condition results in significant morbidity and resource allocation, including prolonged hospital admission. As such, early diagnosis and optimisation of treatment is imperative.
Hamish Moore +2 more
wiley +1 more source
A case report of Stevens-Johnson syndrome and toxic epidermal necrolysis due to diclofenac sodium [PDF]
, 2020 Stevens-Johnson syndrome (SJS) is a severe skin reaction most often triggered by particular drugs in most of the cases. A more severe form of the condition is called toxic epidermal necrolysis (TEN) which involves more than 30% of the skin surface and ...
Bendi, Sreenivasa Rao +1 more
core +2 more sources
Australasian Journal of Dermatology, EarlyView.ABSTRACT Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe skin reaction with high mortality, most often triggered by medications. Early identification of patients at risk is essential for guiding treatment. The SCORTEN score, comprising seven clinical and laboratory variables, is widely used to predict mortality but may ...
Zhao Feng Liu +8 more
wiley +1 more source
Stevens-Johnson syndrome induced by phenytoin: a case report [PDF]
, 2016 Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) are rare (one to two per 10,00,00 population per year) but life threatening adverse drug reactions.
Bhanu, Lalkota Prakash +4 more
core +2 more sources
Pharmacogenomic testing and its future in community pharmacy [PDF]
, 2020 Although it is common to see pharmacogenomic testing used North America and Australia, it is not yet part of practice in the UK. With the promise of genomic screening becoming part of the NHS, pharmacists must equip themselves with a knowledge of how the
Wright, David, Youssef, Essra
core +1 more source
British Journal of Dermatology, 2019 The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the diagnosis and management of the full spectrum of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and SJS-TEN overlap in children (0 ...
T. McPherson +33 more
semanticscholar +1 more source
Contact Dermatitis, EarlyView.This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli +8 more
wiley +1 more source
Journal of Acute Disease, 2019 Rationale: Stevens-Johnson syndrome is a disorder mostly attributed to drug use, which can cause different skin problems. Patient concerns: A 31-year-old woman presented with severe pain and pounding in the left ear.
Keyvan Kiakojuri +5 more
doaj +1 more source